COVID-19 and Sickle Cell Disease in the Province of Quebec, Canada: Outcomes after Two Years of the Pandemic.
Mathias CastonguayNawar DakhallahJustin DesrochesMarie-Laure ColaiacovoCamille Jimenez-CortesAnne-Marie ClaveauSamuel BérubéAmer Yassine HafsaouiAmalia SouzaPauline TiboutChristophe Ah-YanAnne-Marie VincentVeronique NaessensJosée BrossardSharon AbishRaoul SantiagoDenis SoulieresVincent LarocheYves PastoreThai Hoa TranStéphanie FortéPublished in: Journal of clinical medicine (2022)
The SCD population is at higher risk of severe disease than the general population. However, we report favorable outcomes as no deaths occurred. Registries will continue to be critical to document the impact of novel COVID-19 specific therapy and vaccines for the SCD population.